| --- | --- | --- | --- | --- | --- | |-------|-------|-------|------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | 国投证券研究报告 | 2024年9月3 日 | | | | | | | 国投证券消费 | | | | | 2024W35 关 注 | 家电|食饮|医药 | 一 周 看 图 |轻工| 纺服 家 电 | | | | | ...

Investment Rating - The report assigns a "Buy - A" investment rating to the company with a 6-month target price of 9.45 CNY, implying a dynamic P/E ratio of 35.00x for 2024 [5][14]. Core Insights - The company reported a revenue of 19.12 billion CNY for H1 2024, a year-on-year increase of 25.06%, while the net profit attributable to shareholders was 0.692 billion CNY, down 44.53% year-on-year [2]. - The growth in revenue is driven by strong demand for AI terminals, with significant contributions from mobile phones, PCs, tablets, and robotics, although the gross margin has decreased by 5.21 percentage points to 16.53% due to changes in product mix [3][4]. - The company is actively developing products and expanding its customer base in response to the growing demand for AI terminals, with notable growth in the automotive sector, particularly in the electric vehicle market [4]. Summary by Sections Financial Performance - In Q2 2024, the company achieved a revenue of 9.32 billion CNY, a 15.43% increase year-on-year, but a 4.89% decrease quarter-on-quarter. The net profit for the same quarter was 0.231 billion CNY, down 61.54% year-on-year and 49.82% quarter-on-quarter [2]. - The company expects revenue growth rates of 18.3%, 23.8%, and 20.9% for 2024, 2025, and 2026, respectively, with net profit growth rates of -7.2%, 59.1%, and 32.3% for the same years [7][9]. Product Development and Market Trends - The company is focusing on AI terminal-related product development, including carbon fiber components for foldable smartphones and advanced cooling solutions, which are expected to drive future growth [4][14]. - The automotive business has seen a revenue increase of 42.90% year-on-year, reaching 1.018 billion CNY, benefiting from the global growth of the new energy vehicle market [4]. Market Position and Competitive Landscape - The report highlights that the company is well-positioned to benefit from the ongoing technological revolution in the consumer electronics industry, particularly with the rise of AI technologies [7][14]. - The company’s materials business, which includes electromagnetic shielding and thermal materials, is also expected to grow in line with the development of the consumer electronics and new energy vehicle markets [10].

Group 1: Market Overview - 2023 marked a turning point for credit research, with significant redemptions in wealth management breaking previous norms[2] - The emergence of concerns over land finance has elevated the status of bank subordinated bonds in the market[2] - The rapid rotation of bond strategies has made historical comparisons challenging, leading to a process of continuous iteration in credit strategy research[2] Group 2: Credit Strategy Insights - The credit bond market has shifted towards longer durations, with 10-year and above bonds becoming a significant part of the market in 2024[2] - The net price of long credit bonds has risen sharply, showcasing a strong "profit effect" in a bull market environment[2] - Short- to medium-term bank subordinated bonds have benefited from the current market conditions, despite the volatility of credit bonds[2] Group 3: Research Framework Enhancements - The company has expanded its credit strategy monitoring framework to include long credit bond observation systems and quantitative credit strategy returns[2] - The upgraded research framework aims to provide a more practical approach to investment, incorporating various market monitoring angles[2] - Continuous feedback from investors is encouraged to enhance the research process and adapt to market changes[2] Group 4: Risk Considerations - There are risks associated with index variable distortion and the need for adjustments in index calculation methods[2] - The impact of credit events on indices remains a critical area of focus for ongoing research[2]

2024 年 09 月 02 日 邮储银行(601658.SH) 事件：邮储银行披露 2024 年中期报告，2024 年上半年营收增 速为-0.11%；拨备前利润增速为-6.08%；归母净利润增速为1.51%，业绩基本符合预期，我们点评如下： 2024 年第二季度邮储银行归母净利润增速为-1.70%，业绩增长 主要受到规模增长、拨备释放支撑，而净息差收窄、成本上升及 非息收入下降则对业绩增长形成拖累。 量：二季度资产扩张步伐放缓，金融资产增加为主要支撑 ①资产端：2024 年上半年末，邮储银行资产同比扩张 8.53%，增速环 比下降 2.59pct，资产扩张速度有所放缓；生息资产平均余额同比增 长 10.45%，增速环比下降 1.82pct。这主要是因为邮储银行二季度同 业资产大幅减少，同时信贷投放较弱，拖累了规模扩张。 从增量结构来看，邮储银行二季度资产规模扩张主要靠金融资产增 加，贷款投放则受宏观经济影响不及去年同期。其中，金融资产单季 度新增 1432 亿元，同比多增 25 亿元；贷款总额（不含贴现）单季度 新增 964 亿元，同比少增 1254 亿元。从资产结构来看，2024 年二季 度末邮储银行贷款 ...

Investment Rating - The investment rating for BYD is "Buy - A" with a 6-month target price of 274 CNY per share, maintaining the rating [3][7]. Core Views - BYD's August sales reached a record high, with a total of 371,000 passenger vehicles sold, representing a year-on-year increase of 35% and a month-on-month increase of 9%. Electric vehicles (EVs) accounted for 148,000 units sold, up 2% year-on-year and 14% month-on-month, while the DM series saw sales of 222,000 units, up 73% year-on-year and 5% month-on-month [1]. - The company is expected to continue benefiting from the DM5.0 model, which is driving growth in sales. The sales figures for the Dynasty and Ocean series in August were 178,000 and 175,000 units, respectively, with significant year-on-year and month-on-month growth [1]. - The high-end product line is also showing strong performance, with the sales of the Fangcheng Leopard model increasing by 165% month-on-month. The Tengshi and Yangwang brands sold 10,000 and 310 units, respectively, with new models expected to enhance sales further [1][2]. - BYD's export sales in August reached 30,000 units, a year-on-year increase of 22% and a month-on-month increase of 1%. The company is expanding its international presence with new model launches in various countries [1][2]. Summary by Sections Sales Performance - In August, BYD sold 371,000 passenger vehicles, with EVs at 148,000 units and DM models at 222,000 units. Exports were 30,000 units [1]. - The sales of the Qin series were 70,000 units, the Sea Leopard series 55,000 units, and the Song series 77,000 units, showing strong growth across the board [1]. High-End Product Development - The Fangcheng Leopard model sold 4,876 units in August, with a significant month-on-month increase. The Tengshi Z9GT model launch is expected to boost sales further [1][2]. International Expansion - BYD's export strategy is progressing, with a target of 400,000 to 500,000 units for the year. The company is launching models in new markets and increasing local production capacity [2].

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 25.80 CNY, maintaining the rating [1][5]. Core Views - The company is expected to see a continued recovery in profitability in the second half of 2024, with a significant increase in revenue and net profit in the first half of 2024 compared to the previous year [2][5]. - The global artificial turf market is projected to grow at a CAGR of 6.50% from 2023 to 2027, with the company holding a market share of 16.7% in 2023 [3][5]. - The company has made strategic investments in production capacity in Vietnam and Mexico to meet increasing demand from the Americas [4][5]. Financial Performance - In H1 2024, the company achieved revenue of 1.509 billion CNY, a year-on-year increase of 18.82%, and a net profit of 283 million CNY, up 25.08% [2][5]. - The gross margin for H1 2024 was 30.93%, with a net margin of 18.76%, reflecting improvements in operational efficiency [5][7]. - The company expects revenues of 2.904 billion CNY, 3.378 billion CNY, and 3.921 billion CNY for 2024, 2025, and 2026 respectively, with corresponding net profits of 514.6 million CNY, 610.3 million CNY, and 735.7 million CNY [5][6]. Market Dynamics - The overseas revenue for H1 2024 was 1.407 billion CNY, representing a year-on-year growth of 19.30%, primarily driven by the leisure turf segment [3][5]. - The company is actively expanding its market share in the domestic market despite reduced investment in basic sports facilities [3][5]. - The company is well-positioned to benefit from the anticipated easing of inflationary pressures in the US and a resilient macroeconomic environment [3][5].

Investment Rating - The report maintains a "Buy-A" investment rating with a 6-month target price of 42.54 CNY, compared to the current stock price of 30.60 CNY as of August 30, 2024 [1][5]. Core Views - The company's revenue for the first half of 2024 was 1.013 billion CNY, a decrease of 2.94% year-on-year, while net profit dropped by 37.53% to 170 million CNY [1][2]. - The decline in performance is attributed to a high base from the previous year and reduced procurement from hospitals, particularly affecting ultrasound and endoscopy segments [2]. - Despite short-term pressures, the company is increasing investments in market expansion and R&D, which are expected to support long-term growth [2]. Financial Performance - For the first half of 2024, the gross margin was 67.43%, down 1.55 percentage points year-on-year, and the net profit margin was 16.84%, down 9.33 percentage points [1][2]. - The company reported a sales expense ratio of 28.37%, up 6.18 percentage points year-on-year, and a R&D expense ratio of 20.95%, up 4.68 percentage points [2]. - The ultrasound segment saw a revenue of 610 million CNY, a decline of 5.94%, while the endoscopy segment grew slightly by 2.84% to 387 million CNY [3]. Revenue and Profit Forecast - The report forecasts revenue growth rates of 16.3%, 23.2%, and 22.9% for 2024, 2025, and 2026, respectively, with net profit growth rates of 1.3%, 38.0%, and 27.8% for the same years [5][6]. - The projected earnings per share (EPS) for 2024 is 1.06 CNY, with a price-to-earnings (PE) ratio of 28.8 [6][7]. Market Position and Product Development - The company has developed a comprehensive product line in the ultrasound market, including high-end and portable devices, with plans to launch new high-end portable products in 2024 [3]. - In the endoscopy market, the company has introduced several innovative products, including domestically produced high-end endoscopes, which have received positive feedback from top-tier hospitals [3].

Investment Rating - The report maintains a "Buy-A" investment rating with a 6-month target price of 344.84 CNY [4][12] Core Views - The company achieved steady revenue growth in H1 2024, with total revenue reaching 20.53 billion CNY, a year-on-year increase of 11.12%, and net profit of 7.56 billion CNY, up 17.37% [1] - The company’s cash flow from operating activities saw a significant increase of 89.51%, amounting to 8.49 billion CNY [1] - The report highlights the strong growth potential in the company's various business segments, particularly in consumables and international markets [2][3][9] Summary by Sections Financial Performance - In H1 2024, the company reported a gross margin of 66.25%, an increase of 0.65 percentage points year-on-year, and a net profit margin of 36.9%, up 2.03 percentage points [1] - For Q2 2024, the company achieved a revenue of 11.16 billion CNY, a 10.35% increase year-on-year, and a net profit of 4.4 billion CNY, reflecting a 13.69% growth [1] Business Segments - **Life Information and Support**: Revenue decreased by 7.59% to 8.01 billion CNY due to delayed procurement activities, but future demand remains strong with a market potential of over 24 billion CNY [2] - **In Vitro Diagnostics**: This segment saw a revenue increase of 28.16% to 7.658 billion CNY, driven by a growth of over 30% in chemiluminescence business [3] - **Medical Imaging**: Revenue grew by 15.49% to 4.27 billion CNY, with high-end ultrasound products showing over 40% growth [9] Market Outlook - The report indicates that the domestic market for medical infrastructure is expected to release pent-up demand, with a total market space of over 24 billion CNY [2] - The international market is recovering, with the company expanding its presence in high-end hospitals across various countries, leading to double-digit growth in international sales [2] Strategic Initiatives - The company is advancing its digital transformation by integrating AI with its medical solutions, which has generated approximately 4.5 billion CNY in sales over the past three years [10] - The acquisition of Huatai Medical is expected to enhance the company's capabilities in the cardiovascular field, tapping into a market projected to reach 56 billion USD globally [11]

Investment Rating - The report assigns a rating of "Buy - A" for the company [6]. Core Views - The company is undergoing a business transformation, which has led to pressure on its performance in the first half of 2024. Despite this, it has secured a significant contract for the construction of a high-level autonomous driving demonstration area in Beijing, valued at 250 million yuan, which is expected to enhance its capabilities in the integrated vehicle-road-cloud ecosystem [2][5]. - The company reported a revenue of 1.667 billion yuan in the first half of 2024, representing a year-on-year growth of 11.08%. The second quarter alone saw a revenue of 960 million yuan, up 20.91% year-on-year, driven primarily by growth in its intelligent cloud business and semiconductor products [4][5]. Summary by Sections Financial Performance - In the first half of 2024, the company achieved a revenue of 1.667 billion yuan, with a year-on-year increase of 11.08%. The second quarter revenue was 960 million yuan, reflecting a 20.91% increase year-on-year. The intelligent cloud business contributed 1.02 billion yuan, growing by 15.82%, while the semiconductor business generated 253 million yuan, up 13.55% [4][5]. - The gross profit margin for the first half of 2024 was 33.11%, a decrease of 12.51 percentage points compared to the same period last year. This decline is attributed to increased costs from customized navigation services, higher project cloud resource costs, and reduced margins in the semiconductor sector due to intensified competition [4]. Future Projections - The company is projected to generate revenues of 3.64 billion yuan, 4.06 billion yuan, and 4.60 billion yuan for the years 2024, 2025, and 2026, respectively. Net profits are expected to be -879 million yuan, -543 million yuan, and -180 million yuan for the same years [5][10]. - The report sets a target price of 9.19 yuan for the next six months, corresponding to a price-to-sales ratio of 6 times for 2024 [5][6].

Investment Rating - The report maintains an investment rating of "Leading the Market - A" for the industry [5]. Core Viewpoints - The report highlights that short-term pig prices need to focus on the rhythm of market supply and selling sentiment, with an optimistic outlook for the pig price in the fourth quarter [16]. - The poultry sector shows stable prices for broiler chickens, while chick prices are adjusting slightly [22]. - The aquaculture sector's prices remain stable, indicating potential investment opportunities [35]. Summary by Sections 1. Market Overview - The agricultural sector increased by 1.47% this week, outperforming major indices like the CSI 300 and the Shanghai Composite Index [9][10]. - The livestock sector, however, faced challenges, with notable declines in certain stocks [12]. 2. Industry Data Tracking - **Pig Farming**: The average price of live pigs is 19.72 CNY/kg, down 4.18% week-on-week. The average price of piglets is 683 CNY/head, down 0.29% [15][16]. - **Poultry Farming**: The average price of broiler chickens is 7.38 CNY/kg, down 1.34% week-on-week. The price of meat chicks is 3.27 CNY/chick, down 4.11% [22][24]. - **Aquaculture**: Prices for various fish species remain stable, with carp at 19.00 CNY/kg and grass carp at 20.00 CNY/kg [35]. 3. Investment Recommendations - For pig farming, recommended stocks include Wen's Foodstuffs, Muyuan Foods, and Shennong Group. For broiler chicken farming, focus on companies like San Nong Development and Yisheng Group [2]. - The report suggests that the post-cycle sector is expected to see significant performance improvement in the second half of 2024 due to tighter supply and demand dynamics [2]. 4. Recent Industry Events - The report notes that the U.S. soybean sales to China have decreased by 21.9% year-on-year, impacting the overall market dynamics [38]. - Domestic soybean inventories continue to rise, while soybean meal stocks have stabilized, indicating potential price rebounds in the near future [39]. 5. Company Announcements - Companies like Zhongmu Co. and Pengdu Agriculture reported significant declines in net profits for the first half of 2024, reflecting the challenges faced in the industry [55].